Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Investigating the Role of Mtnr1b Rs4753426 Genetic Variant in the Type 2 Diabetes Mellitus Risk



Nasab AF1 ; Meybodi HRA2 ; Afshari M3 ; Sarhangi N2 ; Hasanzad M1
Authors

Source: Iranian Journal of Diabetes and Metabolism Published:2020

Abstract

Background: Type 2 diabetes Mellitus (T2DM) is a multifactorial, polygenic disease caused by impaired insulin secretion, insulin resistance and beta-cell dysfunction. Melatonin is a circadian rhythm regulator and any imbalance in its levels can be related to various metabolic disorders. Melatonin and the genetic variants of MTNR1B gene are reported to be associated with T2DM susceptibility. We investigated the association between rs4753426 variant in the MTNR1B gene and the risk of T2DM in group of Iranian patients. Methods: In this case-control study108 T2DM and 100 normal individuals were recruited to genotyping by PCR-RFLP. Results: It was observed a significant difference in CC, CT, and TT genotypes distribution between T2DM and control groups (P<0.001). Frequency of C allele among cases was significantly lower than controls (8.3% vs. 42.5% respectively, P<0.001) and C allele carriers had a 88% lower risk of developing T2DM than T carriers. Conclusion: Our results showed that the rs4753426 variant of MTNR1B gene could reduce the risk of T2DM developing. © 2020, Tehran University of Medical Sciences. All rights reserved.
Other Related Docs
5. Association Analysis of the Hnf4a Common Genetic Variants With Type 2 Diabetes Mellitus Risk, International Journal of Molecular and Cellular Medicine (2019)
6. Association Analysis of Hhex Gene Variant With Type 2 Diabetes Risk, International Journal of Diabetes in Developing Countries (2021)
10. Kcnq1 Common Genetic Variant and Type 2 Diabetes Mellitus Risk, Journal of Diabetes and Metabolic Disorders (2020)
15. Association Analysis Between the Vdr Gene Variants and Type 2 Diabetes, Journal of Diabetes and Metabolic Disorders (2023)
19. Insulin Signaling Pathway Model in Adipocyte Cells, Current Pharmaceutical Design (2023)